Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs

Circulation

Volumn 101, Issue 2, 2000, Pages 125-130

  Gibson, C Michael ^a,d   Cannon, Christopher P ^c   Murphy, Sabina A ^a   Ryan, Kathryn A ^a   Mesley, Rebecca ^a   Marble, Susan J ^a   McCabe, Carolyn H ^c   Van De Werf, Frans ^b   Braunwald, Eugene ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Mortality; Perfusion; Risk factors; Thrombolysis

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT;

ANGIOCARDIOGRAPHY; ARTICLE; BLOOD CLOT LYSIS; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; HEART INFARCTION; HEART MUSCLE BLOOD FLOW; HEART MUSCLE PERFUSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS;

EID: 0033977923     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.101.2.125     Document Type: Article

References (17)